Skip to main content

Table 1 Baseline characteristics of subjects: individuals with chronic obstructive pulmonary disease (COPD), acute exacerbation of COPD (AECOPD) and controls

From: Low levels of DNA repair enzyme NEIL2 May exacerbate inflammation and genomic damage in subjects with stable COPD and during severe exacerbations

Variable

COPD (n = 16)

n (%) or mean (± SD)

AECOPD (n = 11)

n (%) or mean (± SD)

p-value

Controls

Age (years)

62.6 (3.5)

66.5 (4.9)

0.376

42.1 (range 29–63)

Sex (n)

  

0.900

 

 Male

4(33)

3(27)

 

13 (56)

 Female

12(67)

8(73)

 

10 (44)

Race (n)

  

0.080

 

 White

16 (100)

9 (82)

 

22 (96)

 Black

0

2 (18)

 

0

 Asian

0

0

 

1 (4)

Current Smokers (n)

4 (25.0)

3 (27.0)

0.900

n/s

Total pack years (mean)

42.929 (9.3)

46.8 (26.4)

0.751

n/s

Forced Vital Capacity (FVC) (L)

2.29 (0.8)

1.96 (0.8)

0.355

n/s

Forced Expiratory Volume in one second (FEV1) (L)

1.46 (0.7)

0.88 (0.4)

0.029

n/s

FEV1/FVC (%)

51.5 (12.7)

40.0 (17.92)

0.094

n/s

Diffusing Capacity (DLCO) (ml/min/Hg)

15.87 (5.6); n = 8

9.66 (4.8); n = 6

0.050

n/s

Eosinophils (cells/µl)

190.7 (98.6)

*

n/a

n/s

  1. *not included as all AECOPD individuals received steroids, which may reduce eosinophil levels.
  2. n/s not specified